Mota T, Kwayoyin CAR T, CAR T Therapy, Maganin CAR-T
Matsayin ma'aikatan lafiya a cikin nasarar CAR T Cell therapy
Marasa lafiya da ke fama da jiyya na CAR T-cell na waje don ciwon daji dole ne a kula da su ta ƙungiyar ƙwararrun ƙwararru waɗanda suka haɗa da masu gudanar da aikin jinya, bisa ga fosta da aka gabatar a taron 49th Annual Oncology Nursing Society Conference. ..
Mota-T Ciwon ƙwayar cuta, CAR T Therapy, T-Cell CAR, wakili na chimeric
Zurfafa Zurfi cikin CAR T Cell Therapy: Yaya Aiki yake?
Gano kimiyyar da ke bayan CAR T Cell therapy magani a Indiya! Bincika yadda wannan maganin juyin juya hali ke canza ƙwayoyin garkuwar jikin ku zuwa mayaƙan ciwon daji. Karanta blog ɗinmu yanzu don ƙarin koyo game da wannan maganin ban mamaki da yadda ..
Australia, Mota-T Ciwon ƙwayar cuta, CAR T Therapy, Cartherics
Peter MacCallum Cibiyar Ciwon daji da Cartherics za su yi aiki tare kan ciwon daji na ovarian CAR-T cell far.
Maris 2023: Peter MacCallum Cancer Center (Peter Mac) a Ostiraliya da Cartherics Pty Ltd sun shiga yarjejeniyar ci gaba na haɗin gwiwa (CDPA) don haɓaka CTH-002 don maganin ciwon daji na ovarian. Ku cli..
Arcellx, CAR T Therapy, CART DDBCMA, chimeric antigen receptor, Farashin Pharma, Multi myeloma
YARJEJAR KUSA DA KITE DA ARCELLX DOMIN HADA KYAUTA DA SAMUN SAMUN KASANCEWAR MATSALAR CLINICAL CART-DDBCMA A CIKIN MYELOMA DA YAWA.
SANTA MONICA, Calif. & REDWOOD CITY, Calif. -- (KASUWA WIRE) - Kite, Kamfanin Gileyad (NASDAQ: GILD), da Arcellx, Inc. (NASDAQ: ACLX), a yau sun sanar da rufe kamfanonin' a baya. ya sanar da dabarun duniya..
CAR T Therapy, na rigakafin sel, Kwayoyin SNIP CAR-T, Magungunan Stanford
Masu bincike na Stanford sun gyara ƙwayoyin cutar kansa na CAR-T don a iya sarrafa su da maganin baka
Yuni 2022: Dangane da binciken binciken da Stanford Medicine ya buga kwanan nan a cikin mice, maganin ciwon daji wanda ke amfani da ƙwayoyin rigakafi da aka gyara na majiyyaci don kai hari kan ƙwayoyin cutar kansa.
ƙwayoyin mota, CAR T Therapy, T-Cell CAR, Immunotherapy magani
Za a iya rage lokacin kera CAR T-Cell zuwa kwana ɗaya?
Afrilu 2022: A al'ada, tsarin kera tantanin halitta don CAR T-cell far yana ɗaukar kwanaki tara zuwa sha huɗu; duk da haka, masu bincike a Jami'ar Pennsylvania sun sami damar ƙirƙirar ƙwayoyin CAR T masu aiki tare da ingantattun ƙwayoyin cuta.
CAR T Therapy, Kwayoyin CAR-T, CAR-T immunotherapy, Jonathan S. Serodi, Jaridar Magungunan Gwaji
CAR T-cell far don ciwon nono yana kan katunan
Maris 2022: A cewar masu bincike a Cibiyar Ciwon Kankara ta UNC Lineberger, ƙara ƙaramin sinadari zuwa tsarin jiyya da ake kira chimeric antigen receptor-T (CAR-T) therapy na iya haɓaka tsarin rigakafi na ƙwayoyin T zuwa nasara.
CAR T Cell immunotherapy, CAR T Technology, CAR T Therapy, Gwajin gwaji
CAR-T far, fasahar CAR-T, menene CAR-T cell immunotherapy? Kudin jiyya na CAR-T, sabon aikin gwaji na asibiti na CAR-T
Maris 2022: CAR-T far, CAR-T fasahar, menene CAR-T cell immunotherapy? Farashin jiyya na CAR-T, farashi, sabuwar bayanan daukar ma'aikata na CAR-T na asibiti. Manufar maganin kamun neutron boron ya kasance ..